Playback speed
10 seconds
SABCS 2021 Update on the KEYNOTE-522 Trial of Neoadjuvant Pembro+Chemo vs. Placebo+Chemo Followed by Adjuvant Pembro vs. Placebo in eTNBC: EFS Sensitivity & Subgroup Analyses
By
SABCS 2021 Conference Coverage on VuMedi
FEATURING
Peter Schmid
By
SABCS 2021 Conference Coverage on VuMedi
FEATURING
Peter Schmid
229 views
January 17, 2022
Login to view comments.
Click here to Login